AlphaMark Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-66
Closed -$6K 675
2024
Q2
$6K Buy
+66
New +$5.5K ﹤0.01% 587
2022
Q4
Sell
-389
Closed -$22K 580
2022
Q3
$22K Buy
+389
New +$21.6K 0.01% 302
2021
Q2
Sell
-33
Closed -$2K 568
2021
Q1
$2K Hold
33
﹤0.01% 494
2020
Q4
$2K Hold
33
﹤0.01% 466
2020
Q3
$1K Hold
33
﹤0.01% 508
2020
Q2
$1K Hold
33
﹤0.01% 507
2020
Q1
$1K Hold
33
﹤0.01% 500
2019
Q4
$1K Hold
33
﹤0.01% 466
2019
Q3
$1K Hold
33
﹤0.01% 463
2019
Q2
$1K Hold
33
﹤0.01% 487
2019
Q1
$1K Hold
33
﹤0.01% 468
2018
Q4
$1K Buy
+33
New +$907 ﹤0.01% 452

Other funds holding ACA

AlphaMark Advisors's ACA Position: Q3 2024 in Review

AlphaMark Advisors sold out of Arcosa (ACA) in Q3 2024, closing a stake of 66 shares — an estimated $6K sold.

AlphaMark Advisors first reported a position in ACA in Q4 2018 and held it in 12 quarters. The position peaked at $22K in Q3 2022. 324 funds tracked by Wall St. Rank hold ACA as of Q3 2024.

  • AlphaMark Advisors reported no remaining Arcosa position as of Q3 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 66 Arcosa shares in Q3 2024, an estimated $6K.
  • AlphaMark Advisors first reported a position in Arcosa in Q4 2018 and held it in 12 quarters.
  • AlphaMark Advisors's Arcosa position peaked at $22K in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Arcosa as of Q3 2024.

Based on AlphaMark Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.